Figure 1
From: The cardiovascular safety of incretin-based therapies: a review of the evidence
Mechanisms underlying the putative cardiovascular effects of incretin-based therapies. ANP, atrial natriuretic peptide, IR, ischaemia-reperfusion.
Figure 1 | Cardiovascular Diabetology